Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Management of Temporary Procedure Changes – V 2.0

Posted on By

API Manufacturing: SOP for Management of Temporary Procedure Changes – V 2.0

Standard Operating Procedure for Management of Temporary Procedure Changes in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/195/2025
Supersedes SOP/API/195/2022
Page No. Page 1 of 15
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To define a controlled process for initiating, evaluating, approving, implementing, and reverting temporary changes to standard operating procedures (SOPs), methods, or practices in API manufacturing when urgent or exceptional circumstances demand a deviation from approved processes.

2. Scope

This SOP applies to all temporary changes in manufacturing processes, analytical methods, equipment operation, raw material handling, packaging, cleaning, and documentation in API

facilities. It does not apply to permanent changes, which must follow the Change Control SOP.

3. Responsibilities

  • Initiator (Process Owner): Submits the Temporary Change Request (TCR) with justification.
  • QA Department: Evaluates, reviews, approves, and tracks temporary changes.
  • Functional Departments: Implement approved temporary changes and ensure compliance during the defined period.

4. Accountability

The Head of Quality Assurance is accountable for ensuring all temporary changes are justified, risk-assessed, and managed within regulatory and GMP-compliant frameworks.

See also  API Manufacturing: SOP for Monitoring of Crystallization End-Point - V 2.0

5. Procedure

5.1 Initiation of Temporary Change

  1. The department requiring a temporary change shall complete the Temporary Change Request Form (Annexure-1) detailing:
    • Reason for change
    • Scope and impact
    • Duration of proposed change
    • Risk mitigation strategy
  2. The initiator must submit the form to QA for evaluation.

5.2 Risk Assessment and Impact Evaluation

  1. QA, in consultation with cross-functional teams, shall assess:
    • Impact on product quality, safety, and efficacy
    • Compliance with regulatory filings
    • Documentation and data integrity
    • Training and monitoring requirements
  2. A Risk Assessment Checklist (Annexure-2) must be completed.
  3. If the change impacts a registered dossier, Regulatory Affairs must be consulted.

5.3 Approval of Temporary Change

  1. Upon satisfactory evaluation, QA shall approve or reject the TCR.
  2. Approval shall include:
    • Start and end dates
    • Conditions for execution
    • Monitoring parameters
  3. Final approval shall be documented in the TCR Approval Sheet (Annexure-3).

5.4 Communication and Training

  1. All concerned departments shall be informed of the temporary change.
  2. If required, a training session must be conducted and recorded using the Training Record Log (Annexure-4).

5.5 Implementation and Monitoring

  1. Departments must implement the temporary change only during the approved timeframe.
  2. QA shall conduct periodic checks to ensure compliance using the Temporary Change Monitoring Log (Annexure-5).
  3. Any deviation during implementation must be handled per the Deviation Handling SOP.
See also  API Manufacturing: SOP for QA Oversight During Manufacturing and Packaging - V 2.0

5.6 Reversion to Original Procedure

  1. Upon expiration of the temporary change period:
    • Operations must revert to the original SOP/process.
    • QA shall verify reversion using the Closure Checklist (Annexure-6).
  2. A Temporary Change Closure Report (Annexure-7) must be completed and signed.

5.7 Extension or Conversion to Permanent Change

  1. In case the temporary change is beneficial and intended to continue, the department shall initiate a formal Change Control Request (CCR) and close the TCR accordingly.
  2. QA shall not permit extension beyond 90 calendar days without Head QA authorization and documented justification.

6. Abbreviations

  • TCR: Temporary Change Request
  • QA: Quality Assurance
  • CCR: Change Control Request
  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practices

7. Documents

  1. Temporary Change Request Form (Annexure-1)
  2. Risk Assessment Checklist (Annexure-2)
  3. TCR Approval Sheet (Annexure-3)
  4. Training Record Log (Annexure-4)
  5. Temporary Change Monitoring Log (Annexure-5)
  6. Closure Checklist (Annexure-6)
  7. Temporary Change Closure Report (Annexure-7)

8. References

  • ICH Q9 – Quality Risk Management
  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 211 – GMP for Finished Pharmaceuticals
  • EU GMP Chapter 1 – Pharmaceutical Quality System
See also  API Manufacturing: SOP for Sampling of Viscous and Sticky Materials - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Temporary Change Request Form

Change Title Initiator Department Reason Proposed Duration
Alternate Equipment for Granulation Rajesh Kumar Production Breakdown of primary equipment 7 days

Annexure-2: Risk Assessment Checklist

Parameter Risk Level (Low/Med/High) Mitigation
Impact on Product Quality Medium Increased IPC frequency
Regulatory Impact Low Not registered yet

Annexure-3: TCR Approval Sheet

TCR No. Approved By Effective Date Expiry Date
TCR/2025/014 QA Head 15/04/2025 22/04/2025

Annexure-4: Training Record Log

Date Name Department Trainer Signature
14/04/2025 Sunita Reddy QA QA Officer

Annexure-5: Temporary Change Monitoring Log

Date Parameter Checked Observation Inspector
16/04/2025 IPC Sampling Compliant QA Officer

Annexure-6: Closure Checklist

Checklist Item Status Remarks
Original SOP Re-implemented Yes Completed
Training on Reversion Yes Documented

Annexure-7: Temporary Change Closure Report

TCR No. Date Closed Closed By Remarks
TCR/2025/014 23/04/2025 QA Manager Successfully reverted

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New SOP QA Head
14/04/2025 2.0 Clarified timelines and added risk assessment section Regulatory Compliance QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Biosimilars: SOP for Equipment Logbook Maintenance – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Particulate Matter Testing in Sterile Injections – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version